Cargando…
Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection. In this study, we investigated whether a panel of commercially available antiviral drugs exhibit in vitro anti...
Autores principales: | Tan, Emily L.C., Ooi, Eng Eong, Lin, Chin-Yo, Tan, Hwee Cheng, Ling, Ai Ee, Lim, Bing, Stanton, Lawrence W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323075/ https://www.ncbi.nlm.nih.gov/pubmed/15200845 http://dx.doi.org/10.3201/eid1004.030458 |
Ejemplares similares
-
Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes
por: Gan, Esther Shuyi, et al.
Publicado: (2020) -
Cell Strain-Derived Induced Pluripotent Stem Cells as an Isogenic Approach To Investigate Age-Related Host Response to Flaviviral Infection
por: Bifani, Amanda M., et al.
Publicado: (2022) -
Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
por: Bifani, Amanda Makha, et al.
Publicado: (2021) -
Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003
por: Vega, Vinsensius B, et al.
Publicado: (2004) -
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection
por: Ng, Lisa FP, et al.
Publicado: (2004)